Pharmaceutical Executives Face Prison Time In Case Linked To Opioid Crisis
Click here to view this article at the source publication
Sentencing is scheduled to begin on Monday in the criminal trial of top executives at Insys Therapeutics. This landmark case was the first successful prosecution of high-ranking pharmaceutical executives linked to the opioid crisis, including onetime billionaire John Kapoor.
After a 10-week trial and 15 days of jury deliberations, Kapoor and his four co-defendants were found guilty of racketeering conspiracy in May 2019. This charge is often used to prosecute drug dealers and mob bosses. However, this was a rare case in which the federal government used racketeering to go after corporate executives.